Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
95,77 USD | -1,17 % | -2,47 % | -3,98 % |
Kurzporträt
Mitarbeiterzahl: 14 000
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Consumables
42,9
%
| - | - | 969 | 42,9 % | - |
Vital Care
29,3
%
| - | - | 661 | 29,3 % | - |
Infusion Systems
27,8
%
| 351 | 15,4 % | 629 | 27,8 % | +79,17 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
63,7
%
| 1 460 | 64,0 % | 1 440 | 63,7 % | -1,37 % |
Europe, the Middle East and Africa
16,5
%
| 367 | 16,1 % | 374 | 16,5 % | +1,68 % |
Asia-Pacific
10,7
%
| 257 | 11,3 % | 242 | 10,7 % | -6,03 % |
Other Foreign
9,0
%
| 195 | 8,6 % | 204 | 9,0 % | +4,37 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Vivek Jain
CEO | Chief Executive Officer | 52 | 13.02.14 |
George Lopez
FOU | Founder | 76 | 01.01.84 |
Brian Bonnell
DFI | Director of Finance/CFO | 50 | 01.05.18 |
Chief Tech/Sci/R&D Officer | - | 01.03.15 | |
Chief Operating Officer | 56 | 01.02.17 | |
Thomas D. McCall
IRO | Public Communications Contact | 66 | 01.07.10 |
Daniel Woolson
PRN | Corporate Officer/Principal | 47 | 01.01.17 |
Virginia Sanzone
LAW | General Counsel | 49 | 01.08.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
George Lopez
FOU | Founder | 76 | 01.01.84 |
Director/Board Member | 69 | 05.01.18 | |
Kolleen Kennedy
BRD | Director/Board Member | 63 | 31.12.21 |
Vivek Jain
CEO | Chief Executive Officer | 52 | 13.02.14 |
Elisha Finney
BRD | Director/Board Member | 62 | 08.01.16 |
Donald Abbey
BRD | Director/Board Member | 57 | 05.01.18 |
Director/Board Member | 57 | 15.06.15 | |
Laurie Hernandez
BRD | Director/Board Member | 66 | 01.07.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 24 367 510 | 21 231 963 ( 87,13 %) | 2 428 ( 0,009964 %) | 87,13 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Smiths Medical ASD, Inc.
Smiths Medical ASD, Inc. Medical SpecialtiesHealth Technology Smiths Medical ASD, Inc. manufactures and distributes medical devices. Its products include tracheal tube introducers and guides, pleural catheter with flexible introducer, CADD-solid ambulatory infusion pump, MEDEX accessories, continuous caudal and pediatric epidural trays, SPECTRO2 30 pulse oximeter, C-fuser pressure infuser, and coach 2 incentive spirometer. The firm specialty care areas include adult critical care, cardiology, emergency medicine, general anesthesia, homecare, oncology, and pain management. The company was founded by S. A. Leader in 1940 and is headquartered in Minneapolis, MN. |
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-3,98 % | 2,36 Mrd. | |
-2,53 % | 183 Mrd. | |
-3,52 % | 105 Mrd. | |
+5,33 % | 51,77 Mrd. | |
+16,43 % | 47,29 Mrd. | |
-1,73 % | 40,2 Mrd. | |
+5,66 % | 27,62 Mrd. | |
-2,01 % | 25,51 Mrd. | |
+9,84 % | 24,73 Mrd. | |
-1,87 % | 24,52 Mrd. |
- Börse
- Aktien
- 894139 Aktie
- Unternehmen ICU Medical, Inc.